NSF I/UCRC in Pharmaceutical Processing

普渡大学提议建立一个多所大学的国家科学基金药物加工产学研合作研究中心。合作大学是康涅狄格大学和波多黎各大学。该中心的目的是探索和开发药物加工的新技术，促进工业和学术科学家之间的合作研究项目，并促进跨学科的方法来培训学生在药物工艺研究和开发。中心的组织结构包括一个工业咨询委员会，由每个参与公司的一名成员组成，确定研究重点并批准中心的所有支出。中心主任负责管理中心的日常运作，并与会员公司和大学行政部门保持联系。大学政策委员会保证研究生的研究是适合学位目标的，教师的发展不会因参与中心而受到不利影响，中心的活动是按照大学政策进行的。默克公司已退休的药物研发执行董事Ken Hemilich博士将担任该中心的外部评估员

The University of Purdue proposes to establish a multi-university National Science Foundation Industry/University Cooperative Research Center in Pharmaceutical Processing. Partner universities are the University of Connecticut and the University of Puerto Rico. The purposes of the Center are to explore and develop new technology for pharmaceutical processing, to foster collaborative research projects between industrial and academic scientists, and to promote an interdisciplinary approach to training students in pharmaceutical process research and development. The organizational structure of the Center comprises an Industrial Advisory Board, consisting of one member from each participating company, establishes research priorities and approves all spending by the Center. The Center Director manages day-to-day operation of the Center and acts as liaison with member companies as well as the University administration. The University Policy Committee assures that graduate student research is appropriate for the degree objective, that faculty development is not adversely affected by participation in the Center, and that Center activities are carried out in accordance with University policy. Dr. Ken Hemilich, retired Executive Director of Pharmaceutical Research and Development at Merck, will serve as external evaluator for the Center